| Targeting of erbB3 receptor to overcome resistance in cancer treatment J Ma, H Lyu, J Huang, B Liu Molecular cancer 13, 1-9, 2014 | 184 | 2014 |
| Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells S Wang, J Huang, H Lyu, CK Lee, J Tan, J Wang, B Liu Cell death & disease 4 (3), e556-e556, 2013 | 149 | 2013 |
| Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer Y Wu, H Lyu, H Liu, X Shi, Y Song, B Liu Scientific reports 6 (1), 31093, 2016 | 120 | 2016 |
| Understanding the biology of HER3 receptor as a therapeutic target in human cancer H Lyu, A Han, E Polsdofer, S Liu, B Liu Acta Pharmaceutica Sinica B 8 (4), 503-510, 2018 | 109 | 2018 |
| MicroRNA regulation and therapeutic targeting of survivin in cancer J Huang, H Lyu, J Wang, B Liu American journal of cancer research 5 (1), 20, 2015 | 106 | 2015 |
| Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer J Yuan, H Lv, B Peng, C Wang, Y Yu, Z He Cancer chemotherapy and pharmacology 63, 1103-1110, 2009 | 84 | 2009 |
| The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells J Huang, S Wang, H Lyu, B Cai, XH Yang, J Wang, B Liu Molecular cancer 12, 1-15, 2013 | 80 | 2013 |
| Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer L Luo, Z Zhang, N Qiu, L Ling, X Jia, Y Song, H Li, J Li, H Lyu, H Liu, Z He, ... Nature Communications 12 (1), 2699, 2021 | 62 | 2021 |
| Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer S Wang, J Huang, H Lyu, B Cai, X Yang, F Li, J Tan, SM Edgerton, ... Breast Cancer Research 15, 1-13, 2013 | 58 | 2013 |
| Development of effective therapeutics targeting HER3 for cancer treatment X Liu, S Liu, H Lyu, AI Riker, Y Zhang, B Liu Biological Procedures Online 21, 1-10, 2019 | 57 | 2019 |
| Role of erbB3 receptors in cancer therapeutic resistance Y Lee, J Ma, H Lyu, J Huang, A Kim, B Liu Acta Biochim Biophys Sin 46 (3), 190-198, 2014 | 55 | 2014 |
| Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer H Lyu, S Wang, J Huang, B Wang, Z He, B Liu Cancer letters 420, 97-108, 2018 | 49 | 2018 |
| Expression and functions of the repressor element 1 (RE‐1)‐silencing transcription factor (REST) in breast cancer H Lv, G Pan, G Zheng, X Wu, H Ren, Y Liu, J Wen Journal of cellular biochemistry 110 (4), 968-974, 2010 | 43 | 2010 |
| ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer H Liu, H Lyu, G Jiang, D Chen, S Ruan, S Liu, L Zhou, M Yang, S Zeng, ... Cancer research 82 (21), 3974-3986, 2022 | 39 | 2022 |
| Epigenetic mechanism of survivin dysregulation in human cancer H Lyu, J Huang, Z He, B Liu Science China Life Sciences 61, 808-814, 2018 | 38 | 2018 |
| Elevated expression of semaphorin 5A in human gastric cancer and its implication in carcinogenesis G Pan, H Lv, H Ren, Y Wang, Y Liu, H Jiang, J Wen Life sciences 86 (3-4), 139-144, 2010 | 35 | 2010 |
| MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy W Liu, L Qi, H Lv, X Zu, M Chen, J Wang, L Liu, F Zeng, Y Li BMC cancer 15, 1-11, 2015 | 34 | 2015 |
| Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia J Huang, H Lyu, J Wang, B Liu Cancer letters 366 (2), 160-172, 2015 | 34 | 2015 |
| The erbB3-and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells H Lyu, XH Yang, SM Edgerton, AD Thor, X Wu, Z He, B Liu Oncotarget 7 (3), 2921, 2016 | 33 | 2016 |
| Neuroendocrine differentiation is involved in chemoresistance induced by EGF in prostate cancer cells Y Li, HQ Chen, MF Chen, HZ Liu, YQ Dai, H Lv, XB Zu, L Qi Life sciences 84 (25-26), 882-887, 2009 | 33 | 2009 |
Hongzheng RenMayo Clinic , Rochester,MN在 mayo.edu 的电子邮件经过验证
Hongzheng RenMayo Clinic , Rochester,MN在 mayo.edu 的电子邮件经过验证